Journal
JOURNAL OF THROMBOSIS AND THROMBOLYSIS
Volume 27, Issue 1, Pages 95-104Publisher
SPRINGER
DOI: 10.1007/s11239-007-0187-5
Keywords
Coagulation proteins; Fibrinolytic proteins; Cardiopulmonary bypass
Ask authors/readers for more resources
The development of Cardiopulmonary Bypass (CPB) catopulted the field of cardiothoracic surgery into a new dimension-one that changed the lives of individuals with congenital and acquired heart disease worldwide. Despite its contributions, CPB has clear limitations and creates unique challenges for clinicians and patients alike, stemming from profound hemostatic pertubations and accompanying risk for bleeding and possibly thrombotic complications.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available